vidarabine has been researched along with Kaposi Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruijn, JA; van Groningen, K; van Royen, EA; Wijermans, PW | 1 |
1 other study(ies) available for vidarabine and Kaposi Sarcoma
| Article | Year |
|---|---|
Kaposi's sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia.
Topics: Aged; Antineoplastic Agents; Biopsy; Blood Platelets; HIV Seronegativity; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Subsets; Radionuclide Imaging; Sarcoma, Kaposi; Skin; Technetium Compounds; Thrombocytopenia; Vidarabine | 1994 |